305 related articles for article (PubMed ID: 37887864)
1. Statins and Cardiomyocyte Metabolism, Friend or Foe?
Somers T; Siddiqi S; Morshuis WJ; Russel FGM; Schirris TJJ
J Cardiovasc Dev Dis; 2023 Oct; 10(10):. PubMed ID: 37887864
[TBL] [Abstract][Full Text] [Related]
2. Pleiotropic effects of HMG-CoA reductase inhibitors.
Bocan TM
Curr Opin Investig Drugs; 2002 Sep; 3(9):1312-7. PubMed ID: 12498006
[TBL] [Abstract][Full Text] [Related]
3. Pharmacodynamics and pharmacokinetics of the HMG-CoA reductase inhibitors. Similarities and differences.
Lennernäs H; Fager G
Clin Pharmacokinet; 1997 May; 32(5):403-25. PubMed ID: 9160173
[TBL] [Abstract][Full Text] [Related]
4. Modulatory effects of HMG-CoA reductase inhibitors in diabetic microangiopathy.
Danesh FR; Kanwar YS
FASEB J; 2004 May; 18(7):805-15. PubMed ID: 15117885
[TBL] [Abstract][Full Text] [Related]
5. Pleiotropic effects of statins and related pharmacological experimental approaches.
Alegret M; Silvestre JS
Timely Top Med Cardiovasc Dis; 2007 Apr; 11():E10. PubMed ID: 17473899
[TBL] [Abstract][Full Text] [Related]
6. Pleiotropic effects of statins and related pharmacological experimental approaches.
Alegret M; Silvestre JS
Methods Find Exp Clin Pharmacol; 2006 Nov; 28(9):627-56. PubMed ID: 17200729
[TBL] [Abstract][Full Text] [Related]
7. Pleiotropic effects of statins: evidence against benefits beyond LDL-cholesterol lowering.
Pedersen TR
Am J Cardiovasc Drugs; 2010; 10 Suppl 1():10-7. PubMed ID: 21391729
[TBL] [Abstract][Full Text] [Related]
8. Statins and the Kidney: Friend or Foe?
Honore PM; Jacobs R; Hendrickx I; De Waele E; Van Gorp V; De Regt J; Spapen HD
Blood Purif; 2017; 43(1-3):91-96. PubMed ID: 27951534
[TBL] [Abstract][Full Text] [Related]
9. Effects of HMG-CoA reductase inhibitors on skeletal muscle: are all statins the same?
Evans M; Rees A
Drug Saf; 2002; 25(9):649-63. PubMed ID: 12137559
[TBL] [Abstract][Full Text] [Related]
10. Effects of HMG-CoA reductase inhibitors on coagulation and fibrinolysis processes.
Krysiak R; Okopień B; Herman Z
Drugs; 2003; 63(17):1821-54. PubMed ID: 12921488
[TBL] [Abstract][Full Text] [Related]
11. Endothelial dysfunction, oxidative stress and inflammation in atherosclerosis: beneficial effects of statins.
Lahera V; Goicoechea M; de Vinuesa SG; Miana M; de las Heras N; Cachofeiro V; Luño J
Curr Med Chem; 2007; 14(2):243-8. PubMed ID: 17266583
[TBL] [Abstract][Full Text] [Related]
12. Pleiotropic effects of statins: evidence for benefits beyond LDL-cholesterol lowering.
Marzilli M
Am J Cardiovasc Drugs; 2010; 10 Suppl 1():3-9. PubMed ID: 21391728
[TBL] [Abstract][Full Text] [Related]
13. Adverse effects of statins - mechanisms and consequences.
Bełtowski J; Wójcicka G; Jamroz-Wiśniewska A
Curr Drug Saf; 2009 Sep; 4(3):209-28. PubMed ID: 19534648
[TBL] [Abstract][Full Text] [Related]
14. Comparison of mechanism and functional effects of magnesium and statin pharmaceuticals.
Rosanoff A; Seelig MS
J Am Coll Nutr; 2004 Oct; 23(5):501S-505S. PubMed ID: 15466951
[TBL] [Abstract][Full Text] [Related]
15. Cholesterol-independent effects of statins and new therapeutic targets: ischemic stroke and dementia.
Miida T; Hirayama S; Nakamura Y
J Atheroscler Thromb; 2004; 11(5):253-64. PubMed ID: 15557707
[TBL] [Abstract][Full Text] [Related]
16. Pleiotropic use of Statins as non-lipid-lowering drugs.
Zhang Q; Dong J; Yu Z
Int J Biol Sci; 2020; 16(14):2704-2711. PubMed ID: 33110390
[TBL] [Abstract][Full Text] [Related]
17. [HMG-CoA reductase inhibitors in prevention of cardiovascular diseases: new mechanisms, aspects and trials].
Wojakowski W; Gmiński J
Przegl Lek; 2000; 57(5):291-5. PubMed ID: 11057120
[TBL] [Abstract][Full Text] [Related]
18. Statins: mechanism of action and effects.
Stancu C; Sima A
J Cell Mol Med; 2001; 5(4):378-87. PubMed ID: 12067471
[TBL] [Abstract][Full Text] [Related]
19. HMG-CoA reductase inhibitor fluvastatin prevents angiotensin II-induced cardiac hypertrophy via Rho kinase and inhibition of cyclin D1.
Morikawa-Futamatsu K; Adachi S; Maejima Y; Tamamori-Adachi M; Suzuki J; Kitajima S; Ito H; Isobe M
Life Sci; 2006 Aug; 79(14):1380-90. PubMed ID: 16712874
[TBL] [Abstract][Full Text] [Related]
20. Cardiovascular pleiotropic effects of statins and new onset diabetes: is there a common link: do we need to evaluate the role of KATP channels?
Sehra D; Sehra S; Sehra ST
Expert Opin Drug Saf; 2017 Jul; 16(7):823-831. PubMed ID: 28571494
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
